Ministry of Science and Technology of China,Grant/Award Number:2022YFE0110200;Natural Science Foundation of Jilin Province,Grant/Award Number:20230101037JC;National Natural Science Foundation of China,Grant/Award Numbers:52203198,52025035。
Ultrasound-generated antigens combined with TLR7/8 agonists as adjuvants have demonstrated significant anti-tumor efficacy as an in-situ vaccine.However,the use of TLR7/8 agonists can cause severe inflammatory respons...
supported by the National Science and Technology Major Project of China(Grant No.:2018ZX09711001);Beijing Nova Program(Grant No.:Z211100002121127);Beijing Natural Science Foundation(Grant No.:L212059);Fundamental Research Funds for the Central Universities(Grant No.:3332021101);CAMS Innovation Fund for Medical Sciences(CIFMS,Grant No.:2022-I2M-JB-011).
Lipid nanoemulsions are promising nanodrug delivery carriers that can improve the efficacy and safety of paclitaxel(PTX).However,no intravenous lipid emulsion of PTX has been approved for clinical treatment,and system...
This work was supported by the projets of National Natural Science Foundation of China[81720108033,81930114,and 81874367];Natural Science Foundation_of Guangdong Province[2018B030322011];Natural Science_Foundation for Distinguished Young Scholars of Guangdong Province[2017A030306033].
Ras has long been viewed as a promising target for cancer therapy.Farnesylthiosalicylic acid(FTS),as the only Ras inhibitor has ever entered phase II clinical trials,has yielded disappointing results due to its strong...
supported by Basic Research Program(2016R1C1B3013951,2021R1F1A1061286,and 2021R1A4A3031875)through the National Research Foundation of Korea(NRF)funded by the Korean government(Ministry of Science,ICT,and Future Planning).
Photodynamic therapy(PDT)has been applied in clinical treatment of tumors for a long time.However,insufficient supply of pivotal factors including photosensitizer(PS),light,and oxygen in tumor tissue dramatically redu...
The first antibody-drug conjugate(ADC),Mylotarg,received FDA approval in 2000,and the revolutionary targeted cancer chemotherapy drug,Imatinib(Gleevec),was approved by FDA in 2001.Accordingly,it is an excellent time t...
The first antibody-drug conjugate(ADC),Mylotarg,received FDA approval in 2000,and the revolutionary targeted cancer chemotherapy drug,Imatinib(Gleevec),was approved by FDA in 2001.Accordingly,it is an excellent time t...
National Natural Science Foundation of China (81202480,81302723);Natural Science Foundation of Liaoning Province (2015020749)。
Cancer is a big challenge that has plagued the human beings for ages and one of the most effective treatments is chemotherapy. However, the low tumor-targeting ability limits the wide clinical application of chemother...
supported by the National Natural Science Foundation of China(Nos.81673021 and U1804183);the Scientific and Technological Project of Henan Province(No.182102310117)。
Near-infrared(NIR)light-triggered photothermal therapy(PTT)is a promising treatment strategy for treating cancer.The combination of nanotechnology and NIR has been widely applied.However,the therapeutic efficacy of th...
This work was supported by the National Natural Science Foundation of China(Nos.81803442 and 81703425).
Amino acid transporters,which play a vital role in transporting amino acids for the biosynthesis of mammalian cells,are highly expressed in types of tumors.Increasing studies have shown the feasibility of amino acid t...
supported by the National Nature Science Foundation of China(81672607 and 81500077);the National Key Specialty Construction Project of Clinical Pharmacy(30305030698);the Nature Science Foundation of Beijing(7192143),the Beijing Nova Program(Z171100001117115);the Special Foundation for State Major Research Program of China(2016YFC0106603);the Research Funding of Sichuan Provincial People’s Hospital(2017LY08).
Although targeted therapy has been extensively investigated for breast cancers,a molecular target with broad application is currently unavailable due to the high heterogeneity of these cancers.Mammaglobin-A(Mam-A),whi...